0,849  0,003  5 Hydroxytryptamine release stimulant
0,845  0,002  Dopamine D1 antagonist
0,718  0,003  Alpha 2 adrenoreceptor antagonist
0,702  0,004  Alpha adrenoreceptor antagonist
0,698  0,003  Alpha 2a adrenoreceptor antagonist
0,674  0,010  Antiparkinsonian
0,632  0,007  5 Hydroxytryptamine release inhibitor
0,629  0,012  CYP2C19 substrate
0,619  0,004  Dopamine antagonist
0,604  0,008  Cardiodepressant
0,598  0,003  Pneumotoxic
0,597  0,005  Antiadrenergic
0,603  0,013  Spasmolytic
0,586  0,005  Adrenaline antagonist
0,574  0,004  Dopamine D2 antagonist
0,567  0,004  Dopamine agonist
0,554  0,004  Alpha 1 adrenoreceptor antagonist
0,562  0,014  Cardiovascular analeptic
0,542  0,011  Tumour necrosis factor alpha release inhibitor
0,518  0,009  Sedative
0,542  0,038  Analgesic
0,505  0,003  Dopamine D5 antagonist
0,522  0,022  CYP2D6 substrate
0,507  0,009  Sigma receptor agonist
0,517  0,025  Vasodilator, peripheral
0,495  0,003  LDLR expression enhancer
0,536  0,048  Caspase 9 stimulant
0,495  0,008  Muscle relaxant
0,502  0,020  UGT1A9 substrate
0,517  0,042  Transcription factor NF kappa B inhibitor
0,513  0,043  Antineoplastic (lung cancer)
0,473  0,005  Alpha 1a adrenoreceptor antagonist
0,481  0,028  Antipsychotic
0,489  0,043  CYP3A4 substrate
0,449  0,005  Tyrosine 3 hydroxylase inhibitor
0,472  0,032  Respiratory analeptic
0,459  0,019  Hypoxia-inducible factor 1 alpha inhibitor
0,466  0,038  Aldehyde oxidase inhibitor
0,460  0,034  Antidepressant
0,500  0,074  Apoptosis agonist
0,453  0,029  Cardioprotectant
0,466  0,043  CYP2C9 substrate
0,450  0,041  Prostate cancer treatment
0,432  0,024  Free radical scavenger
0,410  0,008  Antialcoholic
0,403  0,004  Dopamine D2 agonist
0,417  0,020  Dependence treatment
0,447  0,051  Histamine release inhibitor
0,415  0,020  Psychostimulant
0,437  0,042  Mood disorders treatment
0,453  0,065  Antineoplastic (breast cancer)
0,416  0,030  Vasodilator, coronary
0,388  0,004  Alpha adrenoreceptor agonist
0,390  0,010  Skeletal muscle relaxant
0,381  0,004  Alpha 1 adrenoreceptor agonist
0,385  0,013  UGT1A3 substrate
0,442  0,073  Alzheimer's disease treatment
0,403  0,034  CYP2D6 inhibitor
0,396  0,036  Antioxidant
0,392  0,033  UGT2B4 substrate
0,399  0,040  CYP1A2 substrate
0,364  0,007  Cocaine dependence treatment
0,361  0,006  Alpha 2b adrenoreceptor antagonist
0,405  0,052  Antineoplastic (colorectal cancer)
0,396  0,051  Antineoplastic (colon cancer)
0,378  0,034  Radiosensitizer
0,357  0,017  UGT2B7 substrate
0,343  0,005  Alpha 2c adrenoreceptor antagonist
0,388  0,052  Antithrombotic
0,399  0,063  CYP2C19 inhibitor
0,396  0,061  Ulceration
0,391  0,060  Stroke treatment
0,338  0,006  Alpha 1b adrenoreceptor antagonist
0,340  0,012  5 Hydroxytryptamine 1E antagonist
0,366  0,040  Calcium channel activator
0,392  0,069  Antipruritic, allergic
0,355  0,032  Vasodilator
0,366  0,046  Analeptic
0,342  0,024  UGT1A1 substrate
0,310  0,002  Factor III inhibitor
0,311  0,008  Expectorant
0,332  0,031  Antineoplastic enhancer
0,308  0,011  DNA intercalator
0,368  0,074  Antileukemic
0,301  0,011  Topoisomerase I inhibitor
0,348  0,058  Antineoplastic (ovarian cancer)
0,321  0,044  Superoxide dismutase inhibitor
0,279  0,005  Opioid kappa receptor antagonist
0,336  0,063  AR expression inhibitor
0,303  0,032  Anesthetic general
0,289  0,020  Cholinergic
0,270  0,004  Prolactin inhibitor
0,289  0,023  Antineoplastic (squamous cell carcinoma)
0,311  0,047  Antineoplastic (liver cancer)
0,273  0,009  UGT2B1 substrate
0,316  0,053  Antineoplastic (cervical cancer)
0,304  0,043  5 Hydroxytryptamine uptake stimulant
0,328  0,067  Caspase 3 stimulant
0,289  0,030  Antimigraine
0,292  0,037  UDP-glucuronosyltransferase substrate
0,289  0,034  Antihypotensive
0,266  0,011  Toll-Like receptor antagonist
0,297  0,043  Cyclic AMP phosphodiesterase inhibitor
0,298  0,045  UGT1A6 substrate
0,351  0,099  15-Lipoxygenase inhibitor
0,260  0,010  VEGF expression inhibitor
0,297  0,049  Acute neurologic disorders treatment
0,306  0,059  Antineurogenic pain
0,304  0,059  Huntington's disease treatment
0,301  0,057  Antineoplastic (non-small cell lung cancer)
0,256  0,012  UGT2B10 substrate
0,316  0,074  Hepatic disorders treatment
0,264  0,024  UGT2B15 substrate
0,387  0,147  Antiinflammatory
0,241  0,005  Antineoplastic alkaloid
0,243  0,011  5 Hydroxytryptamine 1A antagonist
0,289  0,061  Cardiotonic
0,256  0,029  Tumour necrosis factor antagonist
0,289  0,062  DNA damaging
0,235  0,008  Dopamine D3 antagonist
0,334  0,108  TNF expression inhibitor
0,251  0,025  Tubulin antagonist
0,297  0,073  Antineoplastic (osteosarcoma)
0,235  0,011  Antischistosomal
0,242  0,020  5 Hydroxytryptamine 2B antagonist
0,239  0,017  Antitussive
0,258  0,036  Male reproductive disfunction treatment
0,244  0,022  Toxic, respiratory center
0,269  0,048  Antihypertriglyceridemic
0,247  0,027  Lipid peroxidase inhibitor
0,247  0,028  Attention deficit/hyperactivity disorder treatment
0,244  0,027  Acetylcholine M1 receptor antagonist
0,240  0,023  UGT2B9 substrate
0,221  0,004  Alpha 2 adrenoreceptor agonist
0,271  0,054  Antineoplastic (sarcoma)
0,244  0,028  Protein kinase stimulant
0,236  0,023  5 Hydroxytryptamine 2 antagonist
0,309  0,100  Cognition disorders treatment
0,230  0,022  Uterine stimulant
0,231  0,025  Acetylcholinesterase inhibitor
0,266  0,064  Antiamyloidogenic
0,244  0,043  P-glycoprotein inhibitor
0,242  0,043  UGT1A4 substrate
0,251  0,053  Antiarrhythmic
0,209  0,013  Opioid antagonist
0,240  0,045  Neurotrophic factor enhancer
0,253  0,059  Antimitotic
0,291  0,096  Antiallergic
0,280  0,092  12-Lipoxygenase inhibitor
0,262  0,075  Chemoprotective
0,196  0,010  Alpha 1d adrenoreceptor antagonist
0,220  0,035  Interferon gamma antagonist
0,212  0,028  Antifungal enhancer
0,184  0,003  Dopamine D1 agonist
0,255  0,074  Hypoglycemic
0,237  0,055  Nitric oxide antagonist
0,217  0,037  Antiparkinsonian, tremor relieving
0,195  0,017  5 Hydroxytryptamine 1 antagonist
0,195  0,021  Movement disorders treatment
0,225  0,054  Sleep disorders treatment
0,191  0,020  Antihelmintic (Trematoda)
0,204  0,033  5 Hydroxytryptamine antagonist
0,276  0,107  Antineoplastic (small cell lung cancer)
0,232  0,064  Amyloid beta aggregation inhibitor
0,243  0,076  NOS2 expression inhibitor
0,187  0,021  5 Hydroxytryptamine 2A antagonist
0,239  0,074  DNA synthesis inhibitor
0,199  0,035  NADPH oxidase inhibitor
0,182  0,020  Constipation treatment
0,257  0,095  FMO3 substrate
0,170  0,012  Analgesic, opioid
0,162  0,005  Narcotic antagonist
0,249  0,094  Antineoplastic (melanoma)
0,232  0,083  Antineoplastic (glioma)
0,164  0,014  Opioid mu receptor antagonist
0,201  0,054  Antimutagenic
0,172  0,026  Nav1.1 sodium channel blocker
0,192  0,048  Diuretic
0,146  0,006  Opioid kappa receptor agonist
0,183  0,044  Genotoxic
0,246  0,107  NOS3 expression inhibitor
0,249  0,111  CTGF expression inhibitor
0,149  0,011  Restless leg syndrome treatment
0,313  0,176  Antineoplastic (solid tumors)
0,160  0,024  5 Hydroxytryptamine 2C antagonist
0,220  0,085  Teratogen
0,168  0,033  Cystathionine beta-synthase inhibitor
0,208  0,074  DNA methylase inhibitor
0,173  0,040  Topoisomerase II inhibitor
0,144  0,013  Tourette's syndrome treatment
0,160  0,028  Bronchodilator
0,226  0,095  Proliferative diseases treatment
0,240  0,109  Anxiolytic
0,170  0,039  Toll-Like receptor 2 antagonist
0,183  0,053  Neuropathy treatment
0,145  0,016  Adrenaline agonist
0,132  0,003  Dopamine D5 agonist
0,173  0,045  SULT1A3 substrate
0,200  0,072  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,215  0,087  Cytostatic
0,145  0,018  Dopamine D4 antagonist
0,225  0,099  Interleukin agonist
0,169  0,043  Cholinergic antagonist
0,175  0,050  Erectile dysfunction treatment
0,147  0,023  Toll-Like receptor 4 antagonist
0,166  0,042  Acetylcholine antagonist
0,247  0,122  Interleukin 2 agonist
0,154  0,032  Butyrylcholinesterase inhibitor
0,193  0,073  CYP2B6 inhibitor
0,153  0,034  SULT1A1 substrate
0,140  0,021  Opioid delta receptor antagonist
0,141  0,023  Acetylcholine nicotinic antagonist
0,201  0,085  Antineoplastic (glioblastoma multiforme)
0,137  0,021  UGT2B11 substrate
0,129  0,013  Dopamine uptake inhibitor
0,182  0,068  Antineoplastic (gastric cancer)
0,224  0,110  Antineoplastic (pancreatic cancer)
0,193  0,079  Antiviral (Influenza)
0,269  0,159  Antibacterial
0,158  0,048  M18 aspartyl aminopeptidase inhibitor
0,158  0,048  Bipolar disorder treatment
0,138  0,029  Breast cancer-resistant protein inhibitor
0,153  0,046  Cyclooxygenase 3 inhibitor
0,189  0,083  Cytotoxic
0,127  0,020  Tocolytic
0,147  0,041  Vanilloid 1 agonist
0,116  0,011  Opioid agonist
0,270  0,166  MAP kinase kinase 6 inhibitor
0,144  0,040  Antineoplastic (uterine cancer)
0,155  0,051  Antiseptic
0,156  0,051  Psychosexual dysfunction treatment
0,223  0,119  Antineoplastic (multiple myeloma)
0,118  0,016  HIV-1 integrase inhibitor
0,214  0,113  Radioprotector
0,184  0,084  Non-steroidal antiinflammatory agent
0,159  0,060  Amylase inhibitor
0,160  0,061  Antidiarrheal
0,154  0,056  Adenylate cyclase stimulant
0,113  0,015  Glycine receptor agonist
0,233  0,136  Antihypertensive
0,237  0,140  Apoptosis antagonist
0,144  0,048  Acetylcholine muscarinic antagonist
0,177  0,082  Hepatoprotectant
0,099  0,005  Prolactin release inhibitor
0,117  0,023  Antiprotozoal activity enhancer
0,145  0,051  Antihemorrhagic
0,155  0,062  Hemostatic
0,131  0,038  Estrogen antagonist
0,112  0,019  Beta tubulin antagonist
0,157  0,064  Antineoplastic (carcinoma)
0,107  0,015  Sigma receptor antagonist
0,143  0,052  Antismoking
0,156  0,067  Antidote
0,126  0,039  DOPA decarboxylase inhibitor
0,102  0,016  Beta adrenoreceptor antagonist
0,112  0,026  NMDA 2 receptor antagonist
0,100  0,015  Beta 3 adrenoreceptor antagonist
0,109  0,023  5 Hydroxytryptamine 7 antagonist
0,241  0,156  Immunosuppressant
0,106  0,022  Neuronal nicotinic receptor antagonist
0,243  0,160  Antineoplastic (endocrine cancer)
0,188  0,105  Antineoplastic (lymphoma)
0,104  0,021  HIV-1 integrase (Strand Transfer) inhibitor
0,121  0,039  HIV-1 integrase (Overall Integration) inhibitor
0,204  0,125  Flavin-containing monooxygenase substrate
0,182  0,103  Antiparkinsonian, rigidity relieving
0,133  0,054  Autism spectrum disorders treatment
0,223  0,144  CYP3A4 inhibitor
0,084  0,006  Alpha 1L adrenoreceptor antagonist
0,115  0,038  Estrogen receptor beta antagonist
0,094  0,017  Uterine relaxant
0,177  0,101  Embryotoxic
0,090  0,015  Opioid mu receptor agonist
0,214  0,139  Metabolic disease treatment
0,091  0,017  5 Hydroxytryptamine 1A agonist
0,101  0,027  Estrogen receptor alpha antagonist
0,159  0,085  Antipruritic
0,103  0,030  5 Hydroxytryptamine 1F antagonist
0,078  0,005  Vesicle monoamine transporter inhibitor
0,075  0,004  Guanylate cyclase inhibitor
0,220  0,150  GST M1-1 substrate
0,139  0,069  Neurotrophic factor
0,081  0,012  5 Hydroxytryptamine 7 agonist
0,102  0,033  Granulocyte macrophage colony stimulating factor agonist
0,169  0,100  Abortion inducer
0,100  0,032  Nicotinic alpha4beta2 receptor antagonist
0,100  0,033  mTOR complex 2 inhibitor
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,128  0,061  Alkylator
0,108  0,042  NMDA receptor antagonist
0,072  0,006  Sigma 2 receptor antagonist
0,187  0,122  Vascular (periferal) disease treatment
0,123  0,058  Antifungal (Pneumocystis)
0,105  0,042  Acetylcholine M3 receptor agonist
0,111  0,048  Creatine kinase inhibitor
0,113  0,050  Sulfotransferase substrate
0,133  0,072  Anesthetic
0,081  0,020  NMDA 2B receptor antagonist
0,202  0,143  Antihypoxic
0,113  0,054  Mediator release inhibitor
0,094  0,035  5 Hydroxytryptamine agonist
0,082  0,024  NMDA 2C receptor antagonist
0,233  0,175  Antineoplastic (non-Hodgkin's lymphoma)
0,077  0,020  Potassium channel (Ca-activated) blocker
0,121  0,064  Antiviral (Influenza B)
0,221  0,164  FMO1 substrate
0,077  0,021  Alpha tubulin antagonist
0,139  0,084  Antiviral (Influenza A)
0,156  0,102  Succinate dehydrogenase inhibitor
0,141  0,088  Chemopreventive
0,079  0,028  5 Hydroxytryptamine 2A agonist
0,111  0,060  Electron transport complex I inhibitor
0,196  0,145  Antiischemic
0,057  0,007  Complement C5a chemotactic receptor antagonist
0,089  0,040  CC chemokine 5 receptor agonist
0,111  0,063  Mucolytic
0,063  0,016  Potassium channel small-conductance Ca-activated blocker
0,099  0,052  Protein kinase C zeta inhibitor
0,071  0,025  Beta 1 adrenoreceptor antagonist
0,173  0,127  VCAM1 expression inhibitor
0,080  0,034  5 Hydroxytryptamine uptake inhibitor
0,118  0,072  Antiprotozoal (Amoeba)
0,094  0,051  Insulin growth factor antagonist
0,145  0,102  Antipruritic, non-allergic
0,063  0,020  Topoisomerase II beta inhibitor
0,074  0,031  Adrenaline uptake inhibitor
0,071  0,030  5 Hydroxytryptamine 5A antagonist
0,101  0,060  mTOR complex 1 inhibitor
0,063  0,023  Dopamine transporter inhibitor
0,046  0,007  Nicotinic alpha3beta4 receptor agonist
0,135  0,096  Ca2+-transporting ATPase inhibitor
0,051  0,014  Nociceptin (N/OFQ) receptor antagonist
0,125  0,089  Nav1.6 sodium channel blocker
0,085  0,050  Glycine receptor antagonist
0,042  0,007  Nociceptin (N/OFQ) receptor agonist
0,072  0,038  HIV-1 integrase (3'-Processing) inhibitor
0,067  0,034  Acetylcholine M5 receptor antagonist
0,109  0,076  Microtubule formation inhibitor
0,090  0,058  Phosphodiesterase I inhibitor
0,092  0,060  SULT1E1 substrate
0,126  0,093  Antiischemic, cerebral
0,083  0,052  Phosphodiesterase 11A inhibitor
0,083  0,052  Phosphodiesterase XI inhibitor
0,143  0,113  Aldehyde oxidase substrate
0,059  0,028  5 Hydroxytryptamine 2 agonist
0,057  0,027  Beta 2 adrenoreceptor antagonist
0,063  0,033  5 Hydroxytryptamine 5 antagonist
0,142  0,113  DNA methyltransferase I inhibitor
0,118  0,089  Skin whitener
0,057  0,028  Glucose-6-phosphate translocase inhibitor
0,032  0,004  NMDA receptor phencyclidine site antagonist
0,160  0,133  Antiprotozoal (Leishmania)
0,046  0,018  Phenylethanolamine N methyltransferase inhibitor
0,114  0,088  Gastritis treatment
0,083  0,057  Insulin like growth factor 1 antagonist
0,040  0,015  Melatonin agonist
0,135  0,110  Prostate disorders treatment
0,104  0,079  Anesthetic local
0,135  0,111  Carcinogenic, group 1
0,169  0,146  Age-related macular degeneration treatment
0,205  0,181  Sodium/bile acid cotransporter inhibitor
0,074  0,052  Cushing's syndrome treatment
0,060  0,038  Ryanodine receptor antagonist
0,098  0,076  Choleretic
0,060  0,039  Bcl-xL inhibitor
0,180  0,159  Antidiabetic (type 2)
0,028  0,008  Vesicular acetylcholine transporter inhibitor
0,131  0,112  Melanin inhibitor
0,047  0,028  Phosphodiesterase 3B inhibitor
0,068  0,050  SULT2A1 substrate
0,040  0,024  5 Hydroxytryptamine 2B agonist
0,068  0,053  Prokinetic
0,078  0,063  Phosphodiesterase IV inhibitor
0,080  0,066  Estrogen-related receptor beta agonist
0,035  0,020  Melatonin 2 agonist
0,169  0,155  Nitric-oxide synthase stimulant
0,122  0,110  Heat shock protein 90 antagonist
0,044  0,032  5 Hydroxytryptamine 2C agonist
0,052  0,041  Nicotinic receptor alpha7 subunit antagonist
0,095  0,085  Chelator
0,033  0,023  Catechol O-methyltransferase inhibitor
0,015  0,005  Melatonin 2 antagonist
0,082  0,074  Sodium/hydrogen exchanger 5 inhibitor
0,079  0,072  Vanilloid agonist
0,108  0,101  Toll-Like receptor 9 antagonist
0,086  0,080  Antiemetic
0,033  0,028  Opioid delta receptor agonist
0,100  0,094  Menstruation disorders treatment
0,024  0,020  Sigma 1 receptor antagonist
0,073  0,069  MAP kinase kinase 7 inhibitor
0,071  0,068  Histamine H1 receptor antagonist
0,154  0,152  Antineoplastic (renal cancer)
0,047  0,045  5 Hydroxytryptamine 4 antagonist
0,043  0,042  5 Hydroxytryptamine 1 agonist
0,051  0,050  Postcoital contraceptive

